[1] European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe: annual report of the European antimicrobial resistance surveillance network (EARS-Net). 2014. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf. [2015-11-16].
[2] CDC. Antibiotic resistance threats in the United States, 2013. 2013. https://www.cdc.gov/antimicrobial-resistance/media/pdfs/ar-threats-2013-508.pdf.[2013-04-23].
[3] Wieland K, Chhatwal P, Vonberg RP. Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: results of a systematic review. Am J Infect Control 2018;46(6):643 − 8. https://doi.org/10.1016/j.ajic.2017.12.014.
[4] WHO. WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024. https://www.who.int/publications/i/item/9789240093461.[2024-05-17].
[5] China Antimicrobial Resistance Surveillance System. National bacterial drug resistance surveillance report 2023 (brief version). 2024. https://www.carss.cn/Report/Details?aId=978. (In Chinese). [2024-11-28].
[6] Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study. Lancet 2017;389(10071):805 − 14. https://doi.org/10.1016/S0140-6736(16)31588-4.
[7] Anantharajah A, Goormaghtigh F, Nguvuyla Mantu E, Güler B, Bearzatto B, Momal A, et al. Long-term intensive care unit outbreak of carbapenemase-producing organisms associated with contaminated sink drains. J Hosp Infect 2024;143:38 − 47. https://doi.org/10.1016/j.jhin.2023.10.010.
[8] Grota PG, Grant PS. Environmental infection prevention: priorities of patient safety collaboration. Crit Care Nurs Q 2018;41(1):38 − 46. https://doi.org/10.1097/CNQ.0000000000000184.
[9] Browne K, White NM, Russo PL, Cheng AC, Stewardson AJ, Matterson G, et al. Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial. Lancet Infect Dis 2024;24(12):1347 − 56. https://doi.org/10.1016/S1473-3099(24)00399-2.
[10] Hassoun-Kheir N, Guedes M, Ngo Nsoga MT, Argante L, Arieti F, Gladstone BP, et al. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe. Clin Microbiol Infect 2024;30 Suppl 1:S14-25. http://dx.doi.org/10.1016/j.cmi.2023.09.001.
[11] Kong Y, Liu T, Zhang YR, Wang H, Lin HY. Investigation of an outbreak of carbapenem resistant Acinetobacter baumannii in an intensive care unit during the COVID-19 epidemic. Antimicrob Resist Infect Control 2025;14(1):30. https://doi.org/10.1186/s13756-025-01547-0.
[12] Doi Y, Murray GL, Peleg AY. Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med 2015;36(1):85 − 98. https://doi.org/10.1055/s-0034-1398388.
[13] Cheh-Oh N, Ungthammakhun C, Changpradub D, Santimaleeworagun W. The mortality of colistin monotherapy vs. colistin-sulbactam for carbapenem-resistant Acinetobacter baumannii pneumonia: a propensity score analysis. Infect Chemother 2025;57(1):138 − 47. https://doi.org/10.3947/ic.2024.0125.
[14] Carling PC, Parry MM, Rupp ME, Po JL, Dick B, Von Beheren S, et al. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol 2008;29(11):1035 − 41. https://doi.org/10.1086/591940.